Epithelial cell polarity and improved early outcomes in delayed graft function: A pilot study of polyclonal vs monoclonal antibodies

Nephrology Dialysis Transplantation

Volumn 19, Issue 11, 2004, Pages 2886-2892

  Becker, Yolanda T ^a   Hofmann, R Michael ^a   Yracheta, Joseph ^a   Friedl, Andreas ^b   Becker, Bryan N ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UW Nephrology   (United States)

Author keywords

Antibody therapy; Delayed graft function; Epithelial polarity; Kidney transplantation; Transplant function

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BASILIXIMAB; BETA CATENIN; CORTICOSTEROID; INTERLEUKIN 2 RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYCLONAL ANTIBODY; PREDNISONE; THYMOCYTE ANTIBODY; UVOMORULIN;

ADULT; ARTICLE; CELL POLARITY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CADHERINS; CELL POLARITY; EPITHELIAL CELLS; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; RECOMBINANT FUSION PROTEINS;

EID: 8344282750     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh240     Document Type: Article

References (22)

1. Qureshi F, Rabb H, Kasiske BL. Silent acute rejection during prolonged delayed graft function reduces kidney allograft survival. Transplantation 2002; 74: 1400-1404
2. Nankivell BJ, Fenton-Lee CA, Kuypers DR et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001; 71:515-523
3. Hadley GA, Charandee C, Weir MR, Wang D, Bartlett ST, Drachenberg CB. CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection. Transplantation 2001; 72: 1548-1555
4. Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995; 59: 1683-1689
5. Nankivell BJ, Kuypers DR, Fenton-Lee CA, Allen RD, O'Connell PJ, Chapman JR. Histological injury and renal transplant outcome: the cumulative damage hypothesis. Transplant Proc 2001; 33: 1149-1150
6. Abou-Jaoude MM, Almawi WY. Intraoperative anti-thymocyte globulin-Fresenius (ATG-F) administration as induction immunosuppressive therapy in kidney transplantation. Mol Immunol 2003; 39: 1089-1094
7. Abou-Jaoude MM, Ghantous I, Almawi WY. Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation. Mol Immunol 2003; 39: 1083-1088
8. Goggins WC, Pascual MA, Powelson JA et al. A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003; 76: 798-802
9. Lange H, Muller TF, Ebel H et al. Immediate and long-term results of ATG induction therapy for delayed graft function compared to conventional therapy for immediate graft function. Transplant Int 1999; 12: 2-9
10. Midtvedt K, Fauchald P, Lien B et al. Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection. Clin Transplant 2003; 17: 69-74
11. Simon T, Opelz G, Weimer R et al. The effect of ATG on cytokine and cytotoxic T-lymphocyte gene expression in renal allograft recipients during the early post-transplant period. Clin Transplant 2003; 17: 217-224
12. Gandhi M, Olson JL, Meyer TW. Contribution of tubular injury to loss of remnant kidney function. Kidney Int 1998; 54: 1157-1165
13. +-ATPase during postischemic injury to the renal allograft. Kidney Int 1999; 55: 963-975
14. Miranda KC, Khromykh T, Christy P et al. A dileucine motif targets E-cadherin to the basolateral cell surface in Madin-Darby canine kidney and LLC-PK1 epithelial cells. J Biol Chem 2001; 276: 22565-22572
15. Price VR, Reed CA, Lieberthal W, Schwartz JH. ATP depletion of tubular cells causes dissociation of the zonula adherens and nuclear translocation of beta-catenin and LEF-1. J Am Soc Nephrol 2002; 13: 1152-1161
16. Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 2003; 12: 25-29
17. Pagtalunan ME, Oberbauer R, Haas M et al. Atubular glomeruli in patients with chronic allograft rejection. Transplantation 1996; 61: 1166-1171
18. Michallet MC, Preville X, Flacher M, Fournel S, Genestier L, Revillard JP. Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 2003; 75: 657-662
19. Dragun D, Hoff U, Park JK et al. Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. Kidney Int 2001; 60: 1173-1181
20. Kirby JA, Lin Y, Browell DA et al. Renal allograft rejection: examination of adhesion blockade by antilymphocyte antibody drugs. Nephrol Dial Transplant 1993; 8: 544-550
21. Lu AD, Desai D, Myers BD, Dafoe DC, Alfrey EJ. Excellent outcome despite adverse histology after cadaveric renal transplantation. Transplant Proc 2001; 33: 1148
22. El Asady RS YR, Hadley GA. The role of CD103 (alpha E beta 7 integrin) and other adhesion molecules in lymphocyte migration to organ allografts. Curr Opin Organ Transplant 2003; 8: 49-54